Prospective Sinonasal Cancer Multi-institution Study

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT04755855
Status
Recruiting
Apply to this trial

Conditions

  • Sinonasal Carcinoma

Eligibility Criteria

Sex
ALL
Age
30 Days - 99 Years
Healthy Volunteers
Not accepted

Study Details

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

Key Dates

Start date
Jan 1, 2021
Status verified
Mar 2026
Primary completion
Jan 31, 2031
Completion
Jan 31, 2031

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Oncologic outcomes as measured by overall survival, disease specific survival and recurrence free survival [ Time Frame: Through study completion, an average of 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trials Referral Office
[email protected]
855-776-0015
Jake Eide, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Rochester· Rochester, MN